Ionic Capital Management LLC Bristol Myers Squibb CO Transaction History

Ionic Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $964,516 - $1.26 Million	-19,600 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $437,276 - $483,532	9,800 Added 100.0%	19,600 $889,000
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $924,960 - $1.1 Million	-20,500 Reduced 67.66%	9,800 $468,000
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $999,580 - $1.3 Million	20,500 Added 209.18%	30,300 $1.58 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $2.48 Million - $2.8 Million	-45,000 Reduced 82.12%	9,800 $608,000
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $1.7 Million - $2.12 Million	33,600 Added 158.49%	54,800 $3.03 Million
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $683,088 - $786,372	11,400 Added 116.33%	21,200 $1.34 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $541,254 - $624,652	9,800	9,800 $625,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Ionic Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ionic Capital Management LLC with notifications on news.